Chemotherapy
Cancer prognosis was transformed by the introduction of chemotherapy, but treatment remained non-specific and highly toxic, reducing the overall efficacy and tolerability.
About Xenagos Bio
Transformingprecision oncology.
Xenagos Bio is a precision oncology company developing novel therapies utilizing our proprietary XenaGuide platform to transform cancer treatment.
Our Mission
The right science,plan, and team.
Xenagos Bio was founded on expert oncology research with a singular focus: to advance novel therapeutics with discipline and efficiency.
We pair focused scientific direction with experienced biopharma leadership to build long-term value in oncology.
Why Now
The Evolution of Cancer Therapy is Toward Targeted,Intelligent Treatment
Antibody-Based Targeting
Antibody-based targeting has evolved to improve tumor specificity and enable delivery of numerous payload classes, but antigen escape can eliminate multiple therapeutic classes for a patient simultaneously.
Precision Targeting
A new precision targeting paradigm is needed to overcome the inherent limitations with antibody-based targeting.